Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study
Background/Objectives: Glioblastoma multiforme (GBM) is the most common high-grade primary brain cancer in adults. Despite efforts to advance treatment, GBM remains treatment resistant and inevitably progresses after first-line therapy. Induced neural stem cell (iNSC) therapy is a promising, persona...
Główni autorzy: | , , , |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
MDPI AG
2024-12-01
|
Seria: | Pharmaceutics |
Hasła przedmiotowe: | |
Dostęp online: | https://www.mdpi.com/1999-4923/17/1/3 |